Johns Hopkins Medicine-led team develops fluid biomarker for early detection of ALS and FTD
Two progressively degenerative diseases, amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig’s disease) and frontotemporal dementia (FTD, recently in ...